This year is shaping up to be a solid one for venture-backed IPOs.
Volume picked up in the second and third quarters, and as of mid-November, 71 offerings have taken place. This tops the 70 of 2010 but lags the 86 of 2007.
It is a nice step forward for a market that for many years has been in limbo.
So which firms benefited the most? An analysis of data collected by VCJ publisher Thomson Reuters shows that 187 venture firms and corporate venture arms have had at least one IPO liquidity event so far this year. A total of 31 have had three or more.
This is more broad than last year, when only 17 firms had three or more IPOs to their credit.
At the top of this year’s list is Kleiner Perkins Caufield & Byers, which had seven IPOs to its credit through Nov. 18, including Twitter, Epizyme, Chegg and Veracyte, according to the Thomson Reuters data.
Next up are Meritech Capital Partners, MPM Capital and New Enterprise Associates, each with six. Meritech’s deals include Rally Software Development, Tremor Video and Cyan. MPM was an investor in Portola Pharmaceuticals, Acceleron Pharma and Conatus Pharmaceuticals and NEA backed Tableau Software, Cvent and ChannelAdvisor.
Photo courtesy of Shutterstock